CN Patent

CN104231023B — 三环稠杂环类核苷氨基磷酸酯化合物、其制备方法及应用

Assigned to Nanjing Huicheng Pharmaceutical Co Ltd · Expires 2019-02-05 · 7y expired

What this patent protects

本发明提供了一类三环稠杂环类核苷氨基磷酸酯化合物、其制备方法、含有该核苷氨基磷酸酯化合物的组合物,以及所述化合物或组合物作为病毒感染性疾病治疗药物的用途,特别是作为病毒性肝炎治疗药物的用途。

USPTO Abstract

本发明提供了一类三环稠杂环类核苷氨基磷酸酯化合物、其制备方法、含有该核苷氨基磷酸酯化合物的组合物,以及所述化合物或组合物作为病毒感染性疾病治疗药物的用途,特别是作为病毒性肝炎治疗药物的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN104231023B
Jurisdiction
CN
Classification
Expires
2019-02-05
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Huicheng Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.